Task: Answer the following question about the molecule with SMILES Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1
Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1
(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.